HA-ADT inhibited HCC cells via promoting apoptosis via suppressing the AKT/GSK-3β/β-catenin, and inhibiting autophagy through suppressing TGF-β/Smad2/3 signaling pathways. This evidence concerns the gene SMAD2 and hepatocellular carcinoma.